Skip to main content

Table 3 Risk factors for intervention and control clinics at baseline and 1-year follow-up

From: Evaluation and pilot implementation of essential interventions for the management of hypertension and prevention of cardiovascular diseases in primary health care in the Republic of Tajikistan

Risk factors Baseline (N = 467) Follow-up (N = 618) Baseline vs. Follow-up Differencea Interactionb
    OR (95 % CI)/difference in means P-value P-value
Intervention
  Current smoker, % (n/N) 5.4 (14/260) 7.2 (27/374) 2.059 (0.933–4.545) 0.074 0.829
  Diabetes, % (n/N) 15.8 (41/260) 19.3 (72/374) 1.354 (0.872–2.102) 0.177 0.973
  Newly diagnosed hypertension, % (n/N) 25.4 (66/260) 47.1 (176/374) 2.520 (1.743–3.643) < 0.001 0.184
  History of CVD, % (n/N) 20.0 (52/260) 13.1 (49/374) 0.653 (0.397–1.074) 0.093 0.537
  SBP, mean ± SD 146.52 ± 14.25 137.80 ± 12.07 -8.51 (-10.65–6.37) < 0.001 < 0.001
  DBP, mean ± SD 91.80 ± 9.04 86.61 ± 7.85 -5.30 (-6.65–3.96) < 0.001 < 0.001
Control
  Current smoker, % (n/N) 6.8 (14/207) 9.0 (22/244) 1.869 (0.759–4.598) 0.173  
  Diabetes, % (n/N) 18.8 (39/207) 23.4 (57/244) 1.371 (0.843–2.231) 0.204  
  Newly diagnosed hypertension, % (n/N) 14.0 (29/207) 19.7 (48/244) 1.565 (0.931–2.631) 0.091  
  History of CVD, % (n/N) 41.5 (86/207) 37.7 (92/244) 0.767 (0.509–1.156) 0.205  
  SBP, mean ± SD 142.28 ± 16.58 141.49 ± 14.21 -0.52 (-3.36-2.32) 0.721  
  DBP, mean ± SD 89.83 ± 8.89 89.85 ± 9.29 0.07 (-1.63-1.77) 0.932  
  1. CVD cardiovascular disease; SBP systolic blood pressure; DBP diastolic blood pressure; SD standard deviation; OR odds ratio; CI confidence interval
  2. a Adjusted for age, gender, and clinic.
  3. b Interaction for intervention and control clinics adjusted for age, gender, and clinic.